MCPH7; SCL interrupting locus protein; SCL-interrupting locus protein; SCL/TAL1 interrupting locus; SIL; STIL; STIL_HUMAN; TAL 1 interrupting locus protein; TAL-1-interrupting locus protein.
Also known as
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human STIL
Human, Mouse, Rat
This is a highly specific antibody against STIL.
STIL Primary Polyclonal Antibody
Gene ID number
WB, IHC-P, IF(IHC-P)
WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)
Background of the target antigen
TAL1 disruption at 1p32, a common rearrangement in the T-cell acute lymphoblastic leukemia, usually results in the formation of a SCL interrupting locus (SIL)-TAL1 fusion product. SIL is an immediate early gene whose expression is associated with cell proliferation. The Sil protein exhibits ubiquitous expression in hematopoietic cell lines and tissues. However, Sil protein levels remain tightly regulated during the cell cycle, achieving peak levels in mitosis and diminishing on transition to G1 phase. Overexpression of Sil in primary adenocarcinomas predicts metastatic spread, especially in lung tumors with increased mitotic activity.
1ug per 1ul
This antibody was purified via Protein A.
Cross reactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Keep the antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for up to 1 year.
If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
No similar products groups has been found